Commitments and Contingencies and Supply Source: (Details)	12 Months Ended
	Feb. 28, 2013 item	Feb. 29, 2012 item
Commitments and contingencies and supply source
Number of patients for whose treatment the company produced antineoplaston products	59	90
Number of patients who can be treated per year with the current production capacity of antineoplaston products as estimated by the management	1,500
Dr. Burzynski | Royalty Agreement
Commitments and contingencies and supply source
Number of patients to be treated with antineoplaston products in option two, percentage added to cost of production to determine overall price	10.00%
Dr. Burzynski | Royalty Agreement | Maximum
Commitments and contingencies and supply source
Number of patients to be treated with antineoplaston products under the option in which related party would have the right to produce the products without paying any fees	1,000
Number of patients to be treated with antineoplaston products under the option in which related party would have the right to purchase the products from the company at specified price	1,000